Trident Lifeline Receives 'Buy' Rating from MarketsMOJO, Shows Strong Financial Performance and Positive Outlook.
Trident Lifeline, a microcap pharmaceutical company, has received a 'Buy' rating from MarketsMojo due to its strong financial performance and positive outlook. The company has a low Debt to Equity ratio, impressive long-term growth, and a bullish technical trend. However, investors should also be aware of potential risks such as high ROE and decreasing promoter stake.
Trident Lifeline, a microcap pharmaceutical company, has recently received a 'Buy' rating from MarketsMOJO. This upgrade comes as a result of the company's strong financial performance and positive outlook.One of the key factors contributing to the 'Buy' rating is Trident Lifeline's low Debt to Equity ratio, which is currently at 0 times. This indicates a healthy financial position and the ability to manage debt effectively.
The company has also shown impressive long-term growth, with Net Sales growing at an annual rate of 66.80% and Operating profit at 94.23%. In the latest quarter, the company's Net Sales have grown by 36.79% and its PAT (profit after tax) has increased to Rs 5.39 crore.
From a technical standpoint, the stock is currently in a bullish range and has shown improvement in its technical trend. Factors such as MACD, Bollinger Band, and KST all point towards a bullish outlook for the stock.
However, there are some risks to consider when investing in Trident Lifeline. The company has a high ROE (return on equity) of 19.4, which may make its valuation expensive with a price to book value of 7.7. Additionally, the stock is currently trading at a premium compared to its historical valuations.
Furthermore, while the stock has generated a return of 39.36% in the past year, its profits have only risen by 17%. This results in a PEG ratio of 2.2, which may indicate that the stock is overvalued.
Another potential risk is the decreasing stake of promoters in the company. In the previous quarter, promoters have reduced their stake by -1.97% and currently hold 65.51% of the company. This could suggest a lack of confidence in the future prospects of the business.
In conclusion, Trident Lifeline's recent 'Buy' rating from MarketsMOJO is a result of its strong financial performance and positive outlook. However, investors should also consider the potential risks associated with the stock before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
